Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Solgene: In silica cells

Edward Pope, chairman and CEO, said his idea for the company began with his background in engineering and materials science, specifically with his knowledge of the field of solution gelation. "Sol-gel" processing, he said, has been successfully commercialized as coatings to tint sheet glass, in the production of abrasive

Read the full 496 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers